Last reviewed · How we verify

NCT05499806: BRAINReADAPT

Cohort Study on the Effects of Aging in Acquired Brain Injury Patients

Status unknown Last updated 12 August 2022
What this trial tests

trial in Acquired Brain Injury in 800 participants. Status unknown.

Timeline
18 March 2022
Primary endpoint
1 March 2023
1 February 2024

Quick facts

Lead sponsorUniversity Medical Center Groningen
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment800
Start date18 March 2022
Primary completion1 March 2023
Estimated completion1 February 2024
Sites2 locations across Netherlands

Conditions studied

Sponsor

University Medical Center Groningen

Who can join

Adults 50 to 67, any sex, with Acquired Brain Injury or Subarachnoid Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective cohort study (questionnaires), with an embedded case control study (neuropsychological assessments) in which the data is gathered within a timeframe of 3 years. A group of 700 patients and a group of 100 healthy volunteers will be participating.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acquired Brain Injury

Currently open trials in the same condition.

Other University Medical Center Groningen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing